26 Jan 2009-28 Jan 2009 — Washington DC, USA
The 3 day conference program features a mixture of business, regulatory and scientific topics, with speakers drawn from big pharma/biotech, the regulators and cell and gene therapy developers themselves. Breakout sessions, workshops and panel discussions combine to make the event highly interactive.
Nicola McCall email: nicola@phacilitate.co.uk phone: +44 (0)20 7839 6137
The Grand Hyatt, Washington, USA.
Building on the resounding success of the last 4 Cell & Gene Therapy Forums, the 2009 event will once again provide a highly valuable meeting place for senior level figures driving the transition of these technologies into safe-commercially-viable products.
The 3 day conference program features a mixture of business, regulatory and scientific topics, with speakers drawn from big pharma/biotech, the regulators and cell and gene therapy developers themselves. Breakout sessions, workshops and panel discussions combine to make the event highly interactive.
In 2009, the Cell & Gene Therapy Forum will once again run concurrently with Phacilitate's 7th annual North American Vaccine Forum. Participants will be able to select the conference agenda of greatest current value to themselves and their organization, with all networking opportunities shared between the two events. Breakfast and lunch buffets, extended refreshment breaks and evening receptions will all take place in the shared exhibition area.
To find out further information or to register, please visit the website.